Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview

Area of Science:

• Biochemistry
• Molecular Biology
• Toxicology

Background:

• Mutagenesis and carcinogenesis are complex processes involving genetic mutations and uncontrolled cell growth.
• Inhibitors play a crucial role in modulating these processes, but their mechanisms are not fully understood.
• Host defense mechanisms are intricately linked with the efficacy and action of these inhibitors.

Purpose of the Study:

• To review and classify the known mechanisms of action for inhibitors of mutagenesis and carcinogenesis.
• To provide a framework for understanding how these inhibitors intervene in disease processes.
• To highlight the importance of elucidating these mechanisms for disease prevention.

Main Methods:

• Literature review and synthesis of existing knowledge on inhibitor mechanisms.
• Classification of identified mechanisms based on intervention stage and host defense modulation.
• Analysis of fragmentary data and identification of knowledge gaps.

Main Results:

• Mechanisms of inhibitors were classified into categories based on intervention timing and host defense interactions.
• Many inhibitors act through multiple mechanisms or interact with other agents.
• The beneficial effects of inhibitors can be counter-balanced by adverse reactions due to their complex biological properties.

Conclusions:

• The current understanding of inhibitor mechanisms, though often fragmentary, provides a scientific basis for preventing mutation-related diseases.
• Elucidating underlying mechanisms complements experimental data from mutagenicity and carcinogenicity tests.
• Further research is expected to rapidly expand the database on inhibitor mechanisms, enhancing their application in primary prevention.